PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.78%
Revenue growth above 1.5x MRVL's 3.41%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
11.54%
Gross profit growth above 1.5x MRVL's 4.40%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
30.81%
Positive EBIT growth while MRVL is negative. John Neff might see a substantial edge in operational management.
30.81%
Positive operating income growth while MRVL is negative. John Neff might view this as a competitive edge in operations.
30.60%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
30.00%
Positive EPS growth while MRVL is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
30.91%
Positive diluted EPS growth while MRVL is negative. John Neff might view this as a strong relative advantage in controlling dilution.
1.12%
Share count expansion well above MRVL's 0.02%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.92%
Diluted share count expanding well above MRVL's 0.02%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
8.03%
Positive OCF growth while MRVL is negative. John Neff would see this as a clear operational advantage vs. the competitor.
11.97%
Positive FCF growth while MRVL is negative. John Neff would see a strong competitive edge in net cash generation.
633.56%
Similar 10Y revenue/share CAGR to MRVL's 663.02%. Walter Schloss might see both firms benefiting from the same long-term demand.
82.72%
5Y revenue/share CAGR under 50% of MRVL's 344.08%. Michael Burry would suspect a significant competitive gap or product weakness.
86.88%
3Y revenue/share CAGR at 75-90% of MRVL's 101.35%. Bill Ackman would expect new product strategies to close the gap.
6238.44%
Positive long-term OCF/share growth while MRVL is negative. John Neff would see a structural advantage in sustained cash generation.
41278.76%
Positive OCF/share growth while MRVL is negative. John Neff might see a comparative advantage in operational cash viability.
1144.41%
Positive 3Y OCF/share CAGR while MRVL is negative. John Neff might see a big short-term edge in operational efficiency.
1477.23%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
2644.50%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
2975.01%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
1576.12%
10Y equity/share CAGR above 1.5x MRVL's 794.34%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
113.56%
5Y equity/share CAGR above 1.5x MRVL's 32.55%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
88.08%
3Y equity/share CAGR above 1.5x MRVL's 27.86%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.83%
AR growth is negative/stable vs. MRVL's 24.53%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-16.93%
Inventory is declining while MRVL stands at 10.17%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
8.40%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
6.65%
BV/share growth above 1.5x MRVL's 0.17%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
-0.23%
Our R&D shrinks while MRVL invests at 0.88%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
0.88%
SG&A declining or stable vs. MRVL's 17.93%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.